The technology of the
Gx Inbeneo®:
Gx Inbeneo®:
Ideal for biopharmaceuticals and APIs
We, Gerresheimer AG and Midas Pharma GmbH, decided to join forces and develop the next–generation pre–pressurized & cartridge–based autoinjector. The product offers biotech and pharma companies new possibilities in the treatment of patients with various diseases.
Our Next-Generation Autoinjector
Platform technology designed to fit drug formulations with different properties
- Customizable spring force
- Customizable subcutaneous needle 25, 27, and 29G Thin Wall gauge
- Compatible with 1.5 and 3.0 mL ISO cartridges
- Intended for low and high viscosity (e.g. 100 cP)
- Adaptation for I.M. injections possible
- Adaptation for 5.0 mL cartridges possible
Customer’s benefits
Single-use autoinjector for subcutaneous injection
- Cartridge-based, pre-pressurized cartridge
- Double-sided needle system for reduced injection time
- No contact between the needle and the drug during storage (dry needle)
- Cartridge with baked-on siliconization is possible
- Terminal gas sterilization compatible with biologics
- Air bubble size decrease in cartridge due to pressure
- No seperate spring release mechanism
Your Contact
Dr. Matthias Bauch
Biotechnology & Devices
Global Vice President
Midas Pharma GmbH
Rheinstraße 49
55218 Ingelheim
Germany
Rheinstraße 49
55218 Ingelheim
Germany